News

Nasdaq4y
CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer
ZUG, Switzerland, CAMBRIDGE, Mass., and SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company ...
Business Insider5y
Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development
About Nkarta Nkarta Therapeutics was founded on the proprietary ... Deerfield Management, LSP, Logos Capital, NEA, Novo Holdings A/S, RA Capital Management, Samsara BioCapital and SR One.
pharmaphorum3d
CRISPR Therapeutics begins natural killer cell cancer tie-up with Nkarta
Gene editing firm CRISPR Therapeutics has announced a collaboration with US biotech Nkarta to develop natural killer (NK) cell therapies for cancer. This latest agreement follows a major deal with ...
Business Insider5y
Nkarta Therapeutics Appoints Vice President of Regulatory Affairs
About Nkarta Nkarta Therapeutics was founded on the proprietary ... Deerfield Management, LSP, Logos Capital, NEA, Novo Holdings A/S, RA Capital Management, Samsara BioCapital and SR One.
FierceBiotech1y
Nkarta cell therapy spurs responses in blood cancer, but specific preconditioning needed
Nkarta Therapeutics’ off-the-shelf natural killer cell therapy appears to be most effective against blood cancer when used with a specific lymphodepletion regimen. But that’s not what most ...
pharmaphorum13d
CRISPR Therapeutics begins natural killer cell cancer tie-up with Nkarta
Gene editing firm CRISPR Therapeutics has announced a collaboration with US biotech Nkarta to develop natural killer (NK) cell therapies for cancer. This latest agreement follows a major deal with ...